Par Drugs And Chemicals cash flow

·UnclassifiedChart ›

Latest FY26

Cash from operations: ₹16.4cr+1.7% on FY25
Capital spending: ₹2.0cr+56.7% on FY25
Free cash flow: ₹14.5cr−2.9% on FY25
Cash from financing: ₹0.0crNo figure a year before

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	3.7	3.6	3.4	3.2
	—	0.0	0.0	0.0	0.0
	—	0.0	−1.0	0.0	−0.1
	—	0.0	0.0	−0.0	−0.1
	—	−1.9	0.0	−0.3	0.0
	—	0.7	−1.9	1.2	−0.7
	—	4.7	−3.0	3.3	1.5
	—	0.0	0.0	0.3	−0.0
	—	0.0	0.0	0.1	0.0
	—	−0.1	0.2	0.0	0.3
	—	−0.1	0.1	0.0	0.0
	—	−2.7	5.5	−2.7	−2.6
	—	0.0	0.0	−0.0	0.0
	—	−0.1	−0.8	0.0	1.2
	—	0.0	−0.1	0.0	0.1
	—	−0.0	0.3	−0.1	−0.3
Cash from operating activities
	17.1	17.3	17.9	19.5	15.1
	—	4.2	2.8	5.1	2.6
	—	21.5	20.7	24.6	17.6
	—	5.0	4.5	4.4	4.3
	—	16.4	16.2	20.2	13.4
Cash from investing activities
	—	2.0	1.3	6.1	7.6
	—	0.0	0.0	0.0	0.2
	—	2.1	0.0	0.0	0.0
	—	0.0	25.1	0.0	0.0
	—	1.8	1.0	0.0	0.1
	—	0.0	0.0	0.2	0.0
	—	−2.2	−25.2	−5.8	−7.3
Cash from financing activities
	—	0.0	0.0	0.0	0.0
	—	0.0	0.0	0.0	−0.0
	—	14.3	−9.1	14.4	6.0
	—	14.3	−9.1	14.4	6.0
	—	—	—	36.7	22.2
Reference items
	18.4	17.1	19.5	22.8	18.2
	17.1%	16.5%	19.3%	23.9%	19.0%
	14.5	14.5	14.9	14.2	5.7
	₹11.76	₹11.76	₹12.12	₹11.51	₹4.67
	10.26×	—	—	—	—
	—	1.25×	1.21×	1.40×	1.18×
	—	5.0	4.5	4.4	4.3
	—	—	—	—	0.0

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

PAR₹120.70

Par Drugs And Chemicals Limited

· Unclassified

₹ CrorePeersBALAXI CROWN STEELCITY HINDCON LATTEYS HECPROJECT AIROLAM GROBTEAMcap ₹149 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	3.2	3.4	3.6	3.7	—
+ Finance Costs	0.0	0.0	0.0	0.0	—
+ Interest Income	-0.1	0.0	-1.0	0.0	—
+ Other Non-cash Items	-0.1	-0.0	0.0	0.0	—
+ Other Reconciling Items	0.0	-0.3	0.0	-1.9	—
Changes in Working Capital
+ Inventories	-0.7	1.2	-1.9	0.7	—
+ Trade Receivables — Current	1.5	3.3	-3.0	4.7	—
+ Other Financial Assets — Current	-0.0	0.3	0.0	0.0	—
+ Other Financial Assets — Non-current	0.0	0.1	0.0	0.0	—
+ Other Current Assets	0.3	0.0	0.2	-0.1	—
+ Other Non-current Assets	0.0	0.0	0.1	-0.1	—
+ Trade Payables — Current	-2.6	-2.7	5.5	-2.7	—
+ Other Financial Liabilities — Current	0.0	-0.0	0.0	0.0	—
+ Other Current Liabilities	1.2	0.0	-0.8	-0.1	—
+ Provisions — Current	0.1	0.0	-0.1	0.0	—
+ Provisions — Non-current	-0.3	-0.1	0.3	-0.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	15.1	19.5	17.9	17.3	17.1
+ Total Adjustments (incl. Working Capital)	2.6	5.1	2.8	4.2	—
Cash from Operations (pre-tax)	17.6	24.6	20.7	21.5	—
+ Income Taxes Paid	4.3	4.4	4.5	5.0	—
Cash from Operating Activities	13.4	20.2	16.2	16.4	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	7.6	6.1	1.3	2.0	—
+ Disp of Fixed Assets	0.2	0.0	0.0	0.0	—
+ Acq of Investment Property	0.0	0.0	0.0	2.1	—
+ Acq of Other Long-term Assets	0.0	0.0	25.1	0.0	—
+ Interest Received — Investing	0.1	0.0	1.0	1.8	—
+ Other Inflows / (Outflows) — Investing	0.0	0.2	0.0	0.0	—
Cash from Investing Activities	-7.3	-5.8	-25.2	-2.2	—
Cash from Financing Activities
+ Interest Paid	0.0	0.0	0.0	0.0	—
Cash from Financing Activities	-0.0	0.0	0.0	0.0	—
Net Changes in Cash (pre-FX)	6.0	14.4	-9.1	14.3	—
Net Changes in Cash	6.0	14.4	-9.1	14.3	—
Closing Cash	22.2	36.7	—	—	—
Reference Items
EBITDA	18.2	22.8	19.5	17.1	18.4
EBITDA Margin %	19.02	23.86	19.31	16.53	17.08
Free Cash Flow (CFO − Capex)	5.7	14.2	14.9	14.5	14.5
Free Cash Flow per Basic Share	4.67	11.51	12.12	11.76	11.76
Price to Free Cash Flow	—	—	—	—	10.26
Cash Flow to Net Income	1.18	1.40	1.21	1.25	—
Cash Paid for Taxes	4.3	4.4	4.5	5.0	—
Cash Paid for Interest	0.0	—	—	—	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.